Monash University Nov 21 2024 Monash University drug discovery researchers have found that a natural fat molecule called ‘lipoxin A4’ (LXA4) could significantly reduce inflammation and improve function for diabetic hearts. The preclinical study, published in Cardiovascular Diabetology , found LXA4, which is known for its "calming agent" action in turning off the body's inflammatory response and preventing chronic inflammation, could also serve as a potential new treatment for diabetes-induced